HomepageEarnings Events Newsdesk 3 days ago Merck & Co., Inc. (MRK) Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc. Merck & Co., Inc. (NYSE: MRK) FY 2026 Other Release S&P Global Inc. (SPGI) Announces New Strategic Direction for Upstream Energy Business » « Arrowhead Pharmaceuticals, Inc (ARWR) Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe Newsdesk:
